Juan Aragon
Chief Executive Officer at VISIONEERING TECHNOLOGIES, INC.
Net worth: - $ as of 2024-04-29
Profile
Juan Carlos Aragon is currently the Chief Executive Officer & Executive Director at Visioneering Technologies, Inc. He also holds positions as Chairman at Optometry Giving Sight, Director at the International Agency for the Prevention of Blindness, Director at Vision Aid Overseas, and Director at the Brien Holden Foundation.
Previously, he served as Director at SightGlass Vision, Inc., Director at the Global Myopia Awareness Coalition (GMAC), and President-CooperVision Specialty EyeCare Division at CooperVision, Inc. Dr. Aragon completed his undergraduate degree at Instituto Politecnico Nacional.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-05-23 | 0 ( -.--% ) | - $ | 2024-04-29 |
Juan Aragon active positions
| Companies | Position | Start |
|---|---|---|
| VISIONEERING TECHNOLOGIES, INC. | Chief Executive Officer | 2023-09-30 |
| Optometry Giving Sight | Chairman | - |
International Agency for the Prevention of Blindness
 International Agency for the Prevention of Blindness Miscellaneous Commercial ServicesCommercial Services International Agency for the Prevention of Blindness provides promotional activities for the prevention of blindness. The company was founded in 1975 and is headquartered in London, the United Kingdom. | Director/Board Member | - |
| Vision Aid Overseas | Director/Board Member | - |
Former positions of Juan Aragon
| Companies | Position | End |
|---|---|---|
SightGlass Vision, Inc.
 SightGlass Vision, Inc. Medical SpecialtiesHealth Technology SightGlass Vision, Inc. is an American clinical-stage life sciences company that focuses on ending nearsightedness in children. The private company is based in California and is developing innovative spectacle lenses based on groundbreaking research from the University of Washington. The company's unique diffusion optics technology is aimed at reducing the progression of myopia in children. SightGlass Vision was founded in 2016 by professors Jay and Maureen Neitz, Dr. James Kuchenbecker, and Dr. Thomas Chalberg, who is the CEO of the company. | Director/Board Member | - |
CooperVision, Inc.
 CooperVision, Inc. Medical SpecialtiesHealth Technology CooperVision, Inc. engages in the manufacture of contact lenses. It offers monthly, two-week and daily disposable contact lenses, all featuring advanced materials and optics. The firm’s products include MyDay; clariti 1day , Biofinity , Proclear and Avaira family. The company was founded in 1950 and is headquartered in Victor, NY. | Corporate Officer/Principal | - |
Training of Juan Aragon
| Instituto Politecnico Nacional | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| VISIONEERING TECHNOLOGIES, INC. | Electronic Technology |
| Private companies | 5 |
|---|---|
CooperVision, Inc.
CooperVision, Inc. Medical SpecialtiesHealth Technology CooperVision, Inc. engages in the manufacture of contact lenses. It offers monthly, two-week and daily disposable contact lenses, all featuring advanced materials and optics. The firm’s products include MyDay; clariti 1day , Biofinity , Proclear and Avaira family. The company was founded in 1950 and is headquartered in Victor, NY. | Health Technology |
| Optometry Giving Sight | |
International Agency for the Prevention of Blindness
International Agency for the Prevention of Blindness Miscellaneous Commercial ServicesCommercial Services International Agency for the Prevention of Blindness provides promotional activities for the prevention of blindness. The company was founded in 1975 and is headquartered in London, the United Kingdom. | Commercial Services |
| Vision Aid Overseas | |
SightGlass Vision, Inc.
SightGlass Vision, Inc. Medical SpecialtiesHealth Technology SightGlass Vision, Inc. is an American clinical-stage life sciences company that focuses on ending nearsightedness in children. The private company is based in California and is developing innovative spectacle lenses based on groundbreaking research from the University of Washington. The company's unique diffusion optics technology is aimed at reducing the progression of myopia in children. SightGlass Vision was founded in 2016 by professors Jay and Maureen Neitz, Dr. James Kuchenbecker, and Dr. Thomas Chalberg, who is the CEO of the company. | Health Technology |
- Stock Market
- Insiders
- Juan Aragon
